Log In
BCIQ
Print this Print this
 

LP-306

  Manage Alerts
Collapse Summary General Information
Company Therapix Biosciences Ltd.
DescriptionCannabinoid-based synthetic formulation of THC delivered via a dry-powder inhaler
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat chronic pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today